Biodexa Pharmaceuticals (BDRX) Other Operating Expenses (2021 - 2022)

Biodexa Pharmaceuticals has disclosed Other Operating Expenses across 2 years of filings, most recently posting $2473.5 for Q3 2022.

• In Q3 2022, Other Operating Expenses changed N/A year-over-year to $2473.5; the TTM figure through Dec 2023 stood at $2473.5 (up 104.57% YoY), while the FY2021 annual figure was -$53659.3, up 81.51% from the prior year.
• Other Operating Expenses came in at $2473.5 for Q3 2022 at Biodexa Pharmaceuticals, up from -$56616.4 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $2473.5 in Q3 2022 to a low of -$56616.4 in Q4 2021.